Gene · 4680
Papers1,711
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,711
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hierarchical identification of a transcriptional panel for the histological diagnosis of lung neuroendocrine tumors. | Front Genet | 2022 | 36105102 | PubTator, text mining | PubMed |
| Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma. | Front Immunol | 2022 | 36091049 | PubTator, text mining | PubMed |
| Lipid-Based Nanomaterials for Drug Delivery Systems in Breast Cancer Therapy. | Nanomaterials (Basel) | 2022 | 36079985 | PubTator, text mining | PubMed |
| Downregulation of S100A9 Reverses Cisplatin-Resistance and Inhibits Proliferation and Migration in Hypopharyngeal Carcinoma. | J Oncol | 2022 | 36072966 | PubTator, text mining | PubMed |
| A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis. | Front Oncol | 2022 | 36059616 | PubTator, text mining | PubMed |
| Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer. | J Transl Med | 2022 | 36058934 | PubTator, text mining | PubMed |
| Establish immune-related gene prognostic index for esophageal cancer. | Front Genet | 2022 | 36035171 | PubTator, text mining | PubMed |
| Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review. | Vaccines (Basel) | 2022 | 36016136 | PubTator, text mining | PubMed |
| Maize Flavonoid Biosynthesis, Regulation, and Human Health Relevance: A Review. | Molecules | 2022 | 36014406 | PubTator, text mining | PubMed |
| The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer. | J Pers Med | 2022 | 36013176 | PubTator, text mining | PubMed |
| Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction. | Genes (Basel) | 2022 | 36011285 | PubTator, text mining | PubMed |
| Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study. | Cancers (Basel) | 2022 | 36010914 | PubTator, text mining | PubMed |
| Case report: Successful allogeneic stem cell transplantation in a child with novel GATA2 defect associated B-cell acute lymphoblastic leukemia. | Front Immunol | 2022 | 35983050 | PubTator, text mining | PubMed |
| Flow Cytometric DNA Ploidy Analysis in Haemato-Lymphoid Neoplasms: An Analysis of 132 Cases. | Int J Hematol Oncol Stem Cell Res | 2022 | 35975117 | PubTator, text mining | PubMed |
| Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors. | Genome Med | 2022 | 35974387 | PubTator, text mining | PubMed |
| Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq. | Genome Med | 2022 | 35962452 | PubTator, text mining | PubMed |
| Crohn's Disease, Host-Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches. | Int J Mol Sci | 2022 | 35955491 | PubTator, text mining | PubMed |
| All trans-retinoic acid modulates hyperoxia-induced suppression of NF-kB-dependent Wnt signaling in alveolar A549 epithelial cells. | PLoS One | 2022 | 35947545 | PubTator, text mining | PubMed |
| Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. | J Nanobiotechnology | 2022 | 35933341 | PubTator, text mining | PubMed |
| Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. | Nat Genet | 2022 | 35931863 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4680/papers?page=21